Terms & Conditions of Use
This web site (http://www.teijin-pharma.com/) (hereafter "this site") is operated by Teijin Pharma Limited. (hereafter "Teijin Pharma") .
Please be aware that by using this site, you have agreed to all terms and conditions. If you do not agree with these terms and conditions, please do not use this site.
Copyrights and Commercial Rights
Copyrights and commercial rights for all materials contained on this site (information, documents, text, images, photographs, illustrations, animated data, video data, voice data, music, software and logos, as well as information sent or distributed via email) are retained by Teijin Pharma and the companies of the Teijin Group (hereafter "Teijin Group") or a third party. Accordingly, you may only use these materials for your personal, non-commercial use, within the scope specified on this site and within the scope permitted under copyright law. These materials may not otherwise be copied, downloaded, altered, edited, reproduced or redistributed without the permission of the copyright holder and/or commercial rights holder.
Product names and service names used in this site are trademarks or registered trademarks of the Teijin Group. Other product names and service names used in this site may be protected as their trademarks and/or trade names.
When creating a link to this site, we ask that you observe trademark and other pertinent laws and ordinances. Teijin Pharma shall not in any way be responsible or liable for any loss or damage resulting from the creation links to or association with this site, even if such actions should result in dispute.
Email, Mail Forms and Other Submissions
Teijin Pharma reserves the right to respond or not respond, at its own discretion, to any emails, mail forms or other submissions to this site. Moreover, Teijin Pharma shall not in any way be responsible or liable for any loss or damage resulting from responses to such submissions.
Submission of Suggestions or Ideas
Regarding proposals concerning products, technologies, manufacturing and/or sales methods, designs, etc., submitted to Teijin Phama by its customers, unless Teijin Phama specifically requests customers to do so, Teijin Phama does not receive any proposals from customers.
Teijin Phama takes the utmost care regarding the operation of this site and the information contained herein. However, Teijin Phama makes no representation or warranty of any kind with respect to the reliability, suitability or accuracy of this information. Teijin Phama shall not in any way be responsible or liable for any loss or damage resulting from the use of this site or the information contained herein.
The information contained on this site and the site's URL are subject to change or deletion without prior notice. Teijin Phama also reserves the right to suspend or discontinue operation of this site without prior notice. Teijin Phama shall not in any way be responsible or liable for any loss or damage resulting from such actions.
The information contained on this site does not solicitate an offer to sell or buy stock in Teijin Phama. The information contained on this site should not be used as a basis for investment decisions. Such decisions are solely the responsibility of the investor.
Proper Law and Court of Jurisdiction
The use of this site and this "the Terms and Conditions of Use" shall be construed according to and governed by the laws of Japan. Any and all disputes arising from or relating to this site shall be brought before the Tokyo District Court, in Tokyo, Japan.
In general, this site is prepared using the following technologies:
- CSS2.1 and CSS3
Browsers supporting the above technologies can access this site.
Access to this site has been confirmed with the following browsers as of April 2013. However, screen display may differ depending on the user environment, including the OS and browser.
- Internet Explorer® 9 (normal mode)
- Mozilla Firefox latest version
This site can be printed though the browser menu.
Changing Font Size
Font size on this site can be changed in the browser settings.